Literature DB >> 10651249

Nuclear matrix and protein kinase CK2 signaling.

K Ahmed1.   

Abstract

The dynamic functional nature of the nuclear matrix dictates that it provide a locus for molecules involved in nuclear transduction of signals, such as those participating in cell growth control. Protein kinases are key elements in a variety of signaling mechanisms and certain of these enzymes have been shown to associate with the NM. Among these, the protein ser/thr kinase CK2 has attracted considerable attention because of its involvement in cell growth. NM appears to be a preferential locus for CK2, as evidenced from its rapid modulation in the NM in response to hormonal and growth factor signals. Differential regulation of CK2 is also noted in the transcriptionally active and inactive nucleosomes. A number of potential substrates for CK2 are localized to the NM. Likewise, distinct substrates for CK2 are noted in the transcriptionally active compared with inactive nucleosomes. The dynamics of phosphorylation of these substrates and that of the association of CK2 activity to these fractions suggests that CK2 may play a role in the functional activities of NM and provide a link between the NM and nucleosomes by serving as a factor in promoting the transition of inactive to active nucleosome.

Mesh:

Substances:

Year:  1999        PMID: 10651249     DOI: 10.1615/critreveukargeneexpr.v9.i3-4.170

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  23 in total

1.  Consequences of CK2 signaling to the nuclear matrix.

Authors:  S Yu; H Wang; A Davis; K Ahmed
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

Review 3.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

4.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Modulation of death receptor-mediated apoptosis by CK2.

Authors:  Guixia Wang; Kashif A Ahmad; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

6.  CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

Authors:  Judit Pallares; David Llobet; Maria Santacana; Nuria Eritja; Ana Velasco; Dolors Cuevas; Susana Lopez; Victor Palomar-Asenjo; Andree Yeramian; Xavier Dolcet; Xavier Matias-Guiu
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

7.  The protein kinase 2 inhibitor CX-4945 regulates osteoclast and osteoblast differentiation in vitro.

Authors:  You Hwa Son; Seong Hee Moon; Jiyeon Kim
Journal:  Mol Cells       Date:  2013-10-22       Impact factor: 5.034

Review 8.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

9.  Identification and characterization of proteins that interact with Drosophila melanogaster protein kinase CK2.

Authors:  R L Trott; M Kalive; U Karandikar; R Rummer; C P Bishop; A P Bidwai
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

10.  Response of cancer cells to molecular interruption of the CK2 signal.

Authors:  H Wang; A Davis; S Yu; K Ahmed
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.